Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02133898 · ClinicalTrials.gov registry record · NA
The Use Of L-Methylfolate As A Treatment For Depression
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT02133898 is a NA study that has completed, run by University of Florida. The registered enrollment target is 57 participants.
The verdict
NCT02133898, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
This is an open-label study assessing the efficacy of l-methylfolate as monotherapy in patients with mild to moderate major depressive disorder (MDD). The plan is to enroll 75 patients with mild to moderate MDD based on the Structured Clinical Interview for DSM-IV (SCID) that have a Hamilton Depression Rating Scale-24 (HDRS-24) score between 8-24. The investigators will collect genotype data on methylenetetrahydrofolate Reductase (MTHFR), MTR and MTRR in this patient population. Subjects will be able to receive their genotype results, on request, upon completion of the study. The investigators hypothesize that depressed patients will be more likely to have a mutation in the MTHFR gene
Interventions
- OTHER L-methylfolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-02 |
| Est. Completion | 2023-04-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02133898
The ClinicalTrials.gov registry entry for NCT02133898 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which L-methylfolate is the first listed.
NCT02133898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02133898 about?
NCT02133898 is a clinical study titled "The Use Of L-Methylfolate As A Treatment For Depression". This is an open-label study assessing the efficacy of l-methylfolate as monotherapy in patients with mild to moderate major depressive disorder (MDD). The plan is to enroll 75 patients with mild to moderate MDD based on the Structured Clinical Interview for DSM-IV (SCID) that have a Hamilton Depress...
What is the current status of trial NCT02133898?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2016-02. Estimated completion is 2023-04-04.
What interventions are being tested in trial NCT02133898?
The interventions under investigation include: L-methylfolate (OTHER).
Who is sponsoring clinical trial NCT02133898?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.